New Drug Trial Hope for Multiple Sclerosis Sufferers

The LDN Research Trust launches its fundraising effort with MyCharityPage.com to give hope to the two and a half million MS sufferers worldwide. LDN Research Trust expects to raise two million pounds for a drug trial of LDN (Low Dose Naltrexone) as a treatment for Multiple Sclerosis (MS). There are around 85,000 people in the UK suffering from MS and every week around 50 new cases are diagnosed. LDN is a non toxic drug that is easing the effects of MS for thousands of people throughout the world and is desperately needed to help improve the symptoms of MS. LDN greatly helps with MS at whatever its stage, but because it has not been trialled for MS, very few GPs are prepared to prescribe it.

The trial can change this and give new hope to sufferers of primary, secondary, relapsing and remitting MS. While this is a small budget for a drug trial by many standards, for a small charity like the LDN Research Trust, it’s a great achievement. LDN Research Trust has teamed up with MyCharityPage.com, a new online fundraising website, to make it easy for supporters to make a donation. Fundraisers who would like to support the LDN Research Trust can go to MyCharityPage.com and donate directly to the LDN Research Trust charity. All major credit and debit cards are accepted and gift aid is automatically reclaimed on all eligible donations.

Supporters can fundraise for the LDN Research Trust online at MyCharityPage.com/ldnresearchtrust, where they can create their own fundraising page with a personal URL, email friends and supporters and accept donations online. Using MyCharityPage.com is quick, easy and secure, where 100% of all donations go direct to the LDN Research Trust and no commission, transaction charges or administration fees are deducted.

Source : www.pressdispensary.co.uk